Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.1 INR | -4.47% | -5.26% | -25.97% |
Feb. 17 | Ortin Laboratories Limited Announces Board Appointments | CI |
Feb. 13 | Ortin Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Business Summary
Number of employees: 24
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals, Drugs and Intermediates
100.0
%
| 82 | 100.0 % | 60 | 100.0 % | -26.86% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 82 | 100.0 % | 60 | 100.0 % | -26.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | 58 | 08-01-28 | |
Divya Purswani
CMP | Compliance Officer | - | Feb. 08 |
Director/Board Member | 61 | 08-01-28 | |
Teja Kavuri
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 58 | 08-01-28 | |
Chief Executive Officer | - | - | |
Director/Board Member | 61 | 08-01-28 | |
General Counsel | - | - | |
Director/Board Member | 76 | 14-05-31 | |
Chairman | - | 20-10-22 | |
Pottur Sujatha
BRD | Director/Board Member | 49 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,131,400 | 6,749,316 ( 83.00 %) | 0 | 83.00 % |
Company contact information
Ortin Laboratories Ltd.
D. No. 1-8-B4, Ground Floor, F3 HIG Block-4, Street no. 3
500044, Hyderabad
+91 40 2756 2055
http://www.ortinlabsindia.comSector
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+31.60% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.47% | 243B | |
+7.40% | 205B | |
-6.26% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- ORTINLAB Stock
- ORTINLAB Stock
- Company Ortin Laboratories Limited